Search

Search Constraints

You searched for: Author/Creator Sho, Takuya

Search Results

21. Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling. (25th May 2020)

22. L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis. Issue 8 (6th August 2018)

23. Overestimated renal function in patients with liver cirrhosis predicts poor prognosis. Issue 7 (19th April 2022)

24. Prevalence and characteristics of naturally occurring sofosbuvir resistance‐associated variants in patients with hepatitis C virus genotype 1b infection. Issue 13 (8th April 2016)

25. Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy‐associated hepatitis in Japan. Issue 10 (31st March 2020)

26. Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis. Issue 2 (10th January 2023)

27. Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment. Issue 11 (31st January 2017)

28. Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction. Issue 7 (15th February 2018)

29. Serum granulysin levels as a predictor of serious telaprevir‐induced dermatological reactions. Issue 8 (15th October 2014)

30. The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease. Issue 6 (22nd February 2022)